carbostyril has been researched along with Allergic Contact Dermatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, P; Li, R; Li, W; Liang, K; Ma, W; Wang, Y; Xu, X; Zhao, Y | 1 |
| McFadden, JP; White, JM | 1 |
2 other study(ies) available for carbostyril and Allergic Contact Dermatitis
| Article | Year |
|---|---|
Rebamipide suppresses TNF-α mediated inflammation in vitro and attenuates the severity of dermatitis in mice.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Transformed; Dermatitis, Allergic Contact; Disease Models, Animal; Gene Expression Regulation; Genes, Reporter; Inflammation Mediators; Lymph Nodes; Macrophage Activation; Macrophages; Male; Mice, Inbred C57BL; NF-kappa B; Oxazolone; Quinolones; Severity of Illness Index; Signal Transduction; Skin; Tumor Necrosis Factor-alpha | 2015 |
Reduced frequency of atopic dermatitis in quinoline-allergic patients: the 'hapten-atopy hypothesis'.
Topics: Adolescent; Adult; Anti-Infective Agents; Child; Child, Preschool; Dermatitis, Allergic Contact; Dermatitis, Atopic; Drug Administration Routes; Female; Gastrointestinal Tract; Haptens; Humans; Immune Tolerance; Infant; Male; Middle Aged; Neomycin; Patch Tests; Quinolones; Retrospective Studies; Skin | 2008 |